Suciu, I.; Delp, J.; Gutbier, S.; Suess, J.; Henschke, L.; Celardo, I.; Mayer, T.U.; Amelio, I.; Leist, M.
Definition of the Neurotoxicity-Associated Metabolic Signature Triggered by Berberine and Other Respiratory Chain Inhibitors. Antioxidants 2024, 13, 49.
https://doi.org/10.3390/antiox13010049
AMA Style
Suciu I, Delp J, Gutbier S, Suess J, Henschke L, Celardo I, Mayer TU, Amelio I, Leist M.
Definition of the Neurotoxicity-Associated Metabolic Signature Triggered by Berberine and Other Respiratory Chain Inhibitors. Antioxidants. 2024; 13(1):49.
https://doi.org/10.3390/antiox13010049
Chicago/Turabian Style
Suciu, Ilinca, Johannes Delp, Simon Gutbier, Julian Suess, Lars Henschke, Ivana Celardo, Thomas U. Mayer, Ivano Amelio, and Marcel Leist.
2024. "Definition of the Neurotoxicity-Associated Metabolic Signature Triggered by Berberine and Other Respiratory Chain Inhibitors" Antioxidants 13, no. 1: 49.
https://doi.org/10.3390/antiox13010049
APA Style
Suciu, I., Delp, J., Gutbier, S., Suess, J., Henschke, L., Celardo, I., Mayer, T. U., Amelio, I., & Leist, M.
(2024). Definition of the Neurotoxicity-Associated Metabolic Signature Triggered by Berberine and Other Respiratory Chain Inhibitors. Antioxidants, 13(1), 49.
https://doi.org/10.3390/antiox13010049
